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This Month in the Journal
Racial and Ethnic Categories in Genetics, by the
Race, Ethnicity, and Genetics Working Group (p. 519)
This month in the Journal, the Race, Ethnicity, and Ge-
netics Working Group of the National Human Genome
Research Institute provides their view of human genetic
variation and how it ﬁts with the complicated concepts
of race, ethnicity, and ancestry. They discuss these inter-
actions in terms both of how these concepts relate to
studies of population history and of how racial/ethnic
categories can be a hindrance or a tool in genetic asso-
ciation studies. Rather than guidelines for the use of race,
ethnicity, and ancestry in genetic research, this review
provides food for thought, and theWorking Group urges
researchers to proceed sensitively, with the hope that
genetic research will eventually reduce racial and ethnic
discrimination.
PTPN22 Genetic Variation, by Carlton et al. (p. 567)
Recent reports of the association of PTPN22 with sev-
eral autoimmune diseases have provided more concrete
evidence that there may be common risk alleles under-
lying at least some forms of autoimmune dysfunction.
R620W was ﬁrst identiﬁed as the risk allele in this gene,
an idea that is supported by functional data showing that
the minor allele affects binding of PTPN22 to its partner,
Csk. This SNP has been the focus of several subsequent
studies, but it has not been demonstrated to be the sole
risk factor for autoimmune disease in this gene. To dis-
sect PTPN22 further, Carlton et al. sequenced the coding
regions of 48 individuals with rheumatoid arthritis (RA)
and selected putative functional and tagging SNPs to
genotype in two independent RA case-control samples.
The W620 risk allele was found on a single haplotype
that differed from a second haplotype at that SNP only.
Of these two haplotypes, only the one carrying W620
showed association with RA, which indicates that none
of the other SNPs marking those haplotypes conferred
risk of the phenotype. However, R620W alone does not
fully account for PTPN22-associated risk of RA in these
samples; three additional SNPs were consistently asso-
ciated with RA independent of R620W, although they
may not function independent of each other. In conjunc-
tion with W620, the risk allele at SNP37 is sufﬁcient to
explain the association of PTPN22 with RA in one of
their samples. This study conﬁrms the importance of
R620W in risk of autoimmune disease, but it indicates
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that there is additional variation in this gene, including
SNP37, that also makes a contribution.
Combined Genomewide Linkage of BP, by McQueen
et al. (p. 582)
Several genome scans for bipolar disorder (BP) have been
performed, but, as with many other complex traits, con-
sistent replication of linkage signals has been lacking. To
summarize the results from these studies, one can do a
meta-analysis, an approach that has yielded some prom-
ising results in the past.McQueen et al.wonderedwhether
they could extract more power still from the individual
genome scans if they combined the raw genotype data
instead of the results of the individual BP scans. Com-
bining the data in this way allowed them to control for
some of the potential sources of variability between stud-
ies, such as differences in disease classiﬁcation.With data
from 15,000 individuals from 11 studies, they achieved
genomewide signiﬁcance at loci on chromosomes 6q and
8q, neither of which was signiﬁcant in the individual
scans or in the previous meta-analyses for BP. Although
this type of study takes a large amount of collaborative
effort, it appears that this can be a powerful way to look
at genome-scan data from many sources, even when the
individual scans haven’t provided consistent results be-
tween them.
XPNPEP2 Associated with Angioedema-ACEi, by
Duan et al. (p. 617)
Millions of people take angiotensin I–converting en-
zyme inhibitors (ACEi) for the treatment of cardiovas-
cular disease. A small percentage of these individuals
will develop a potentially fatal adverse reaction to these
drugs called “angioedema.” Unfortunately, we can’t yet
identify the people at risk of this complication. Because
lower plasma aminopeptidase P (APP) activities have
been reported in people with a history of angioedema
associated with ACEi therapy (AE-ACEi), Duan et al.
wondered whether they could ﬁnd QTLs regulating APP
activity that might then give them a way to determine
genetic risk of AE-ACEi. Through use of eight affected
families, they found linkage of plasma APP activity to a
marker within XPNPEP2, a gene that encodes the mem-
brane-bound form of APP. On closer examination of this
gene, Duan et al. found that one family carried a trun-
cating deletion in XPNPEP2, whereas a variant allele at
a SNP upstream of XPNPEP2 was present in seven of
the families. This SNP association accounts for most of
the linkage signal to the XPNPEP2 region, and, in a
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separate case-control sample, it is associated with AE-
ACEi. These results could be an entre´e into pharmaco-
genetics for ACEi. At this point, however, it is clear that
low APP levels do not explain all cases of AE-ACEi, so—
even if these results are replicated—genetic testing for
XPNPEP2 variation will not identify everyone who is
vulnerable to AE-ACEi.
Sex and Recombination Levels, by Lynn et al. (p. 670)
Recombination is a common and necessary part of the
mechanisms that ensure proper segregation of homolo-
gous chromosomes during meiosis. Although the process
is incompletely understood, recognition of the factors that
affect recombination rates and patterns is helping to elu-
cidate how recombination is regulated. It is known that
the frequency and location of exchange events in males
is different than that in females. In an effort to under-
stand these sex-speciﬁc variations, work has been done
in Drosophila and in the medaka ﬁsh to examine whether
it is the genotype or the sexual environment of the cell
that is important in determination of how recombination
will proceed. Lynn et al. evaluate the question further
by studying the situation in mice with unusual sex-chro-
mosome compositions. These included sex-reversed XY
female mice, which were generated through transfer of
a Y chromosome from Mus domesticus poschiavinus to
a C57BL/6J background, as well as XO females that were
generated on the same background. It is observed that
recombination in sex-reversed females, as well as in fe-
males with an XO genotype, occurs at the same rate and
in similar patterns as for normal females. Of note, re-
combination of meiotic chromosomes in males with the
special Y chromosome resembles that of normal males.
These data demonstrate that the regulation of recombi-
nation is primarily dependent on the phenotypic sex of
the mice and is not due to their genotype.
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